Fill Patterns of Glucose-Lowering Drugs with Cardiovascular and Kidney Benefits in the Rural and Urban United States, 2012–2021
GLP1RA and SGLT2i fills increased over time but remained low overall. They were filled more often by younger people, women, those with ASCVD or CKD (but not with HF), and in small towns.
Authors
- Rozalina Grubina McCoy (ORCID: https://orcid.org/0000-0002-2289-3183)
- Jeph Herrin (ORCID: https://orcid.org/0000-0002-3671-3622)
- Kyle Steiger (ORCID: https://orcid.org/0000-0001-9321-4443)
- Kavya Swarna
Institutions
- University of Maryland, Baltimore (US)
- Mayo Clinic (US)
- Yale University (US)
- Optum (United States) (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Journal of General Internal Medicine
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1007/s11606-025-09784-0
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases